Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Hersch

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of Huntington'S Disease|August 6, 2019
The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research ParticipationElise Kayson, Shirley Eberly, Karen E Anderson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentSteven Hersch, Michelle Gee, Thomas Doherty, et al.
Analytical Biochemistry|February 19, 2013
A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington diseaseBeena Thomas, Samantha Matson, Vanita Chopra, et al.
The EMBO Journal|January 16, 2010
The PTB domain of ShcA couples receptor activation to the cytoskeletal regulator IQGAP1Matthew J Smith, W Rod Hardy, Guang-Yao Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2025
Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open-label extension studyChristopher H van Dyck, Reisa Sperling, Keith Johnson, et al.
Future Science OA|July 10, 2019
The current state of biomarker research for Friedreich's ataxia: a report from the 2018 FARA biomarker meetingIan A Blair, Jennifer Farmer, Steven Hersch, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2007
A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouseVanita Chopra, Jonathan H Fox, Greg Lieberman, et al.
Plos One|March 31, 2007
Mechanisms of copper ion mediated Huntington's disease progressionJonathan H Fox, Jibrin A Kama, Gregory Lieberman, et al.
Plos One|October 23, 2013
Iron accumulates in Huntington's disease neurons: protection by deferoxamineJianfang Chen, Eileen Marks, Barry Lai, et al.
Plos Currents|February 1, 2011
Optimization of an HTRF Assay for the Detection of Soluble Mutant Huntingtin in Human Buffy Coats: A Potential Biomarker in Blood for Huntington DiseaseMiriam Moscovitch-Lopatin, Andreas Weiss, Herminia Diana Rosas, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Huntington'S Disease|August 6, 2019
The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research ParticipationElise Kayson, Shirley Eberly, Karen E Anderson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentSteven Hersch, Michelle Gee, Thomas Doherty, et al.
Analytical Biochemistry|February 19, 2013
A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington diseaseBeena Thomas, Samantha Matson, Vanita Chopra, et al.
The EMBO Journal|January 16, 2010
The PTB domain of ShcA couples receptor activation to the cytoskeletal regulator IQGAP1Matthew J Smith, W Rod Hardy, Guang-Yao Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2025
Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open-label extension studyChristopher H van Dyck, Reisa Sperling, Keith Johnson, et al.
Future Science OA|July 10, 2019
The current state of biomarker research for Friedreich's ataxia: a report from the 2018 FARA biomarker meetingIan A Blair, Jennifer Farmer, Steven Hersch, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2007
A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouseVanita Chopra, Jonathan H Fox, Greg Lieberman, et al.
Plos One|March 31, 2007
Mechanisms of copper ion mediated Huntington's disease progressionJonathan H Fox, Jibrin A Kama, Gregory Lieberman, et al.
Plos One|October 23, 2013
Iron accumulates in Huntington's disease neurons: protection by deferoxamineJianfang Chen, Eileen Marks, Barry Lai, et al.
Plos Currents|February 1, 2011
Optimization of an HTRF Assay for the Detection of Soluble Mutant Huntingtin in Human Buffy Coats: A Potential Biomarker in Blood for Huntington DiseaseMiriam Moscovitch-Lopatin, Andreas Weiss, Herminia Diana Rosas, et al.
Pageof 5